Ovarian tissue storage is the storage of ovarian tissue, often prior to cancer treatments, in hopes of extracting viable eggs from the tissue sample for future fertilization. This process is still considered experimental, however, advancements in medicine have made this procedure more common in the past several years. The tissue is typically removed through laparoscopy and cryopreserved until the patient is ready and wanting to start a family. At that time, the tissue is transplanted back to the patient and natural pregnancy occurs or hormone treatments are given to stimulate ovulation for IVF.
Most women choose to store ovarian tissue because they will be undergoing cancer treatment therapies that may affect their future fertility. This type of reproductive storage is commonly associated with oncology patients because it allows for a relatively quick retrieval (1 – 2 days) and therefore only a short postponement of chemotherapy or radiotherapy.
At ReproTech, our one and only job is storage. It’s all we do, and we do it well. Since 1990, we’ve been at the forefront of cryostorage for a range of reproductive specimens. With our industry expertise, we are able to provide the best value through our tried and tested methods perfected over the past three decades. Because of this experience, we know how to provide cost-effective cryostorage to both individuals and clinics nationwide.
Ovarian tissue storage appointments are available for scheduling within one to three days of your initial call. While it is advantageous for patients to bank all frozen ovarian tissue specimens prior to beginning cancer treatment therapies that can result in infertility, recent studies have shown that viable samples can be collected in the early stages of some treatments. To begin the process of freezing ovarian tissue, please visit our Network of Freezing Centers to find an Ovarian Tissue Freezing Center near you.
To find more information on the long-term storage of your frozen ovarian tissue, please click the location nearest you:
ReproTech is also working with the National Physicians Cooperative of the Oncofertility Consortium, a multi-site NIH grant funded study looking at new options for ovarian tissue cryopreservation and use. ReproTech will be providing the cryostorage services for this ground breaking research. Cancer patients who are participants in the ovarian tissue program will have an ovary surgically removed and cryopreserved before they begin treatment. Twenty percent of the ovarian tissue will be used for research and eighty percent cryopreserved for the patient to use in the future.
The goal of cryopreserving ovarian tissue is to thaw the tissue when the patient is ready to have children. The thawed ovarian follicles are matured in a special gel made from brown algae that supports its three-dimensional development. The mature eggs would then be fertilized and implanted. The laparoscopic removal of an ovary does not require a significant delay in cancer treatment beyond one to two days of recovery. Additionally, infants as young as 6 months can undergo this procedure because neither puberty nor fertilization are required.
Contact ReproTech for options for final disposition of reproductive tissue once your reproductive tissue storage needs have ended.
As the leader in long-term storage, ReproTech is offering the latest innovation in cryostorage planning. The Fertility Preservation Trust is personalized to reflect your unique maintenance and disposition wishes today, and allows you to amend your trust in the future to conform to changing life circumstances. By establishing a special trust for your frozen embryos, eggs, sperm, or reproductive tissue, you gain flexibility, control and protection for the future. To learn more and begin customizing your trust, visit the Fertility Preservation Trust website or email Ashley Pittman at firstname.lastname@example.org.